AFLCIO.org profiled the successful partnership between organized labor and the biopharmaceutical industry as they work together to foster good jobs and help increase access to high-quality affordable health care.
Most Recent Posts
Below is the latest guest post in our "Part D Perspectives" series, which we'll be hosting during the 2013 Medicare Part D Open Enrollment Period (Oct. 12 - Dec. 7).
Clinical trials are a critical part of the development of innovative medicines that deliver life-saving benefits to patients.
As one of the founders of a global clinical research organization (CRO) and as current Chair of ACRO, the trade association for CROs, I can assure you that the pharmaceutical, biotechnology and CRO industries are dedicated to the protection, safety, priv
Many times, we have written in this space about clinical trials of new medicines and how they are beneficial not only to patients, but also the economy and the advancement of science and patient care.
Diabetes affects so many people in so many ways. PhRMA joined participants from around the area for a recent Step Out: Walk to Stop Diabetes event.
One of the most important aspects living with diabetes is adherence. When a diabetic fails to take care of themselves, an otherwise manageable disease can quickly turn into a hospital admission, or worse. As part of Diabetes Awareness Month and our focus on keeping people healthy, we have a guest blog post from policy analyst Nick McNeill from NEHI, a national health policy institute. He breaks down a new NEHI report about the link between adherence and hospital readmission rates.
We continue to focus on diabetes [visit the Medicines in Development for Diabetes resource center] with a guest post from Novo Nordisk's Ken Inchausti.